Penobscot Investment Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.17M Sell
26,577
-1,709
-6% -$256K 0.29% 82
2026
Q1
$4.32M Sell
28,286
-30
-0.1% -$4.6K 0.34% 71
2025
Q4
$3.9M Sell
28,316
-1
-0% -$131 0.29% 77
2025
Q3
$3.63M Buy
28,317
+2,550
+10% +$311K 0.28% 78
2025
Q2
$3.12M Hold
25,767
0.27% 81
2025
Q1
$2.87M Buy
25,767
+1,550
+6% +$165K 0.27% 82
2024
Q4
$2.36M Sell
24,217
-750
-3% -$80K 0.21% 97
2024
Q3
$2.87M Buy
24,967
+200
+0.8% +$22.7K 0.26% 83
2024
Q2
$2.64M Buy
24,767
+6,265
+34% +$629K 0.25% 79
2024
Q1
$1.79M Buy
18,502
+445
+2% +$45.6K 0.19% 109
2023
Q4
$1.82M Buy
18,057
+3,489
+24% +$337K 0.21% 97
2023
Q3
$1.48M Buy
14,568
+10,943
+302% +$1.11M 0.2% 107
2023
Q2
$366K Sell
3,625
-450
-11% -$45K 0.06% 171
2023
Q1
$375K Hold
4,075
0.07% 169
2022
Q4
$370K Hold
4,075
0.06% 172
2022
Q3
$310K Hold
4,075
0.06% 180
2022
Q2
$345K Hold
4,075
0.06% 176
2022
Q1
$358K Hold
4,075
0.05% 188
2021
Q4
$356K Sell
4,075
-100
-2% -$8.3K 0.05% 196
2021
Q3
$342K Sell
4,175
-895
-18% -$80.5K 0.05% 194
2021
Q2
$463K Sell
5,070
-2,750
-35% -$245K 0.07% 164
2021
Q1
$668K Sell
7,820
-675
-8% -$60.6K 0.11% 142
2020
Q4
$802K Sell
8,495
-600
-7% -$52.4K 0.13% 127
2020
Q3
$790K Sell
9,095
-880
-9% -$76.2K 0.15% 124
2020
Q2
$871K Sell
9,975
-150
-1% -$12.9K 0.18% 107
2020
Q1
$835K Sell
10,125
-86
-0.8% -$7.67K 0.2% 105
2019
Q4
$967K Sell
10,211
-330
-3% -$29.6K 0.18% 111
2019
Q3
$916K Sell
10,541
-270
-2% -$24.2K 0.18% 112
2019
Q2
$988K Sell
10,811
-1,366
-11% -$116K 0.2% 104
2019
Q1
$1.05M Sell
12,177
-502
-4% -$40.3K 0.22% 99
2018
Q4
$974K Sell
12,679
-770
-6% -$59.9K 0.23% 98
2018
Q3
$1.04M Sell
13,449
-530
-4% -$39.2K 0.22% 103
2018
Q2
$946K Sell
13,979
-2,979
-18% -$206K 0.22% 104
2018
Q1
$1.23M Buy
16,958
+12,465
+277% +$949K 0.29% 88
2017
Q4
$338K Hold
4,493
0.09% 150
2017
Q3
$346K Hold
4,493
0.1% 149
2017
Q2
$336K Sell
4,493
-391
-8% -$27.7K 0.11% 149
2017
Q1
$325K Sell
4,884
-491
-9% -$32.7K 0.11% 146
2016
Q4
$351K Sell
5,375
-178
-3% -$11.5K 0.12% 135
2016
Q3
$393K Sell
5,553
-882
-14% -$64.3K 0.14% 131
2016
Q2
$476K Sell
6,435
-8,962
-58% -$619K 0.17% 115
2016
Q1
$999K Sell
15,397
-5,277
-26% -$359K 0.37% 79
2015
Q4
$1.59M Buy
20,674
+2,009
+11% +$160K 0.5% 65
2015
Q3
$1.54M Buy
18,665
+3,379
+22% +$301K 0.52% 63
2015
Q2
$1.35M Buy
15,286
+915
+6% +$83.9K 0.42% 70
2015
Q1
$1.27M Hold
14,371
0.4% 76
2014
Q4
$1.19M Hold
14,371
0.38% 78
2014
Q3
$1.21M Sell
14,371
-524
-4% -$42.4K 0.4% 74
2014
Q2
$1.21M Buy
14,895
+54
+0.4% +$4.25K 0.41% 72
2014
Q1
$1.13M Buy
14,841
+335
+2% +$24.4K 0.4% 71
2013
Q4
$1.04M Sell
14,506
-44
-0.3% -$3.06K 0.37% 75
2013
Q3
$1M Sell
14,550
-406
-3% -$26.9K 0.39% 71
2013
Q2
$947K Buy
+14,956
New +$973K 0.39% 69

Other funds holding NVS

Penobscot Investment Management's NVS Position: Q2 2026 in Review

Penobscot Investment Management reduced its Novartis (NVS) stake by 6% in Q2 2026, selling an estimated $256K and leaving 26,577 shares worth $4.17M. The position accounts for 0.29% of the portfolio, ranked #82.

Penobscot Investment Management first reported a position in NVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.32M in Q1 2026. 1,611 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Penobscot Investment Management held 26,577 shares of Novartis worth $4.17M as of Q2 2026.
  • Penobscot Investment Management sold 1,709 Novartis shares in Q2 2026, an estimated $256K.
  • Novartis made up 0.29% of Penobscot Investment Management's portfolio in Q2 2026, its #82 holding.
  • Penobscot Investment Management first reported a position in Novartis in Q2 2013 and has held it in 53 quarters since.
  • Penobscot Investment Management's Novartis position peaked at $4.32M in Q1 2026.
  • 1,611 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Penobscot Investment Management's 13F filing for Q2 2026, filed 24 Jul 2026.